Normal dopamine transporter imaging does not exclude multiple system atrophy

Parkinsonism and Related Disorders

Volumn 20, Issue 8, 2014, Pages 933-934

  McKinley, John ^a   O'Connell, Martin ^a   Farrell, Michael ^b   Lynch, Timothy ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b BEAUMONT HOSPITAL   (Ireland)

Author keywords

Dopamine transporter imaging; MSA; SPECT

Indexed keywords

ALPHA SYNUCLEIN; IOFLUPANE I 123; LEVODOPA; 2-CARBOMETHOXY-8-(3-FLUOROPROPYL)-3-(4-IODOPHENYL)TROPANE; DOPAMINE TRANSPORTER; RADIOPHARMACEUTICAL AGENT; TROPANE DERIVATIVE;

ADULT; AKINESIA; AUTOPSY; BLADDER DISEASE; BLADDER TRABECULATION; CASE REPORT; ECHOGRAPHY; ELECTROMYOGRAPHY; ERECTILE DYSFUNCTION; FAINTNESS; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; HYDRONEPHROSIS; IMPAIRED BLADDER EMPTYING; KIDNEY DYSFUNCTION; LEG MUSCLE; LETTER; LUNG EMBOLISM; MALE; MIDDLE AGED; MUSCLE BIOPSY; MUSCLE DENERVATION; MUSCLE DISEASE; MUSCLE RIGIDITY; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PHYSICAL EXAMINATION; PRESYNCOPE; PRIORITY JOURNAL; RECURRENT DISEASE; SHY DRAGER SYNDROME; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SLURRED SPEECH; UNSTEADINESS; WALKING DIFFICULTY; DIAGNOSTIC USE; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING;

DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TROPANES;

EID: 84905219049     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.04.022     Document Type: Letter

References (8)

1. Jellinger K.A., Seppi K., Wenning G.K. Grading of neuropathology in multiple system atrophy: proposal of a novel scale. Mov Disord 2005, 20(Suppl. 12):S29-S36.
2. Munoz E., Iranzo A., Rauek S., Lomena F., Gallego J., Ros D., et al. Subclinical nigrostriatal dopaminergic denervation in the cerebellar subtype of multiple system atrophy (MSA-C). J Neurol 2011, 258(12):2248-2253.
3. 123I]-FP-CIT study group. Mov Disord 2000, 15(3):503-510.
4. 123I-ioflupane on diagnosis and managements of patients with clinically uncertain parkinsonian syndromes. Mov Disord 2004, 19(10):1175-1182.
5. 123I]-FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Eur J Nucl Med 2001, 28(3):266-272.
6. Wenning G.K., Tison F., Shlomo B., Daniel S.E., Quinn N.P. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997, 12(2):133-147.
7. Ozawa T., Paviour D., Quinn N.P., Josephs K.A., Sangha H., Kilford L., et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 2004, 127:2657-2671.
8. Shy G.M., Drager G.A. A neurological syndrome associated with orthostatic hypotension. A clinic-pathologic study. Arch Neurol 1960, 2:511-527.